Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
N/A x N/A 6.84 x 1
Pre-market by (Cboe BZX)
5.84 unch (unch) 04/02/25 [NYSE]
N/A x N/A 6.84 x 1
Pre-market 5.84 unch (unch) 19:00 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
5.84
Day High
5.86
Open 5.84
Previous Close 5.84 5.84
Volume 753,600 753,600
Avg Vol 1,229,855 1,229,855
Stochastic %K 87.27% 87.27%
Weighted Alpha -45.12 -45.12
5-Day Change -0.01 (-0.17%) -0.01 (-0.17%)
52-Week Range 3.16 - 13.84 3.16 - 13.84
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 224,093
  • Shares Outstanding, K 38,372
  • Annual Sales, $ 408,520 K
  • Annual Income, $ -113,440 K
  • EBIT $ -85 M
  • EBITDA $ -33 M
  • 60-Month Beta 0.82
  • Price/Sales 0.55
  • Price/Cash Flow N/A
  • Price/Book 0.95
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.28
  • Most Recent Earnings $-0.64 on 03/04/25
  • Next Earnings Date 05/06/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.91
  • Number of Estimates 4
  • High Estimate -0.78
  • Low Estimate -0.97
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.72 +2.10%
on 03/03/25
Period Open: 5.72
5.86 -0.34%
on 04/02/25
+0.12 (+2.10%)
since 02/28/25
3-Month
3.16 +84.52%
on 01/10/25
Period Open: 3.71
5.86 -0.34%
on 04/02/25
+2.13 (+57.41%)
since 01/02/25
52-Week
3.16 +84.52%
on 01/10/25
Period Open: 12.73
13.84 -57.80%
on 04/09/24
-6.89 (-54.12%)
since 04/02/24

Most Recent Stories

More News
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per share of...

NVRO : 5.84 (unch)
AVAH : 4.37 (+3.55%)
MASI : 152.07 (+1.90%)
ATEC : 10.83 (+1.79%)
Nevro: Q4 Earnings Snapshot

Nevro: Q4 Earnings Snapshot

NVRO : 5.84 (unch)
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 15.43 (+1.65%)
NVRO : 5.84 (unch)
ARAY : 1.5200 (+4.83%)
MASI : 152.07 (+1.90%)
Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX

For Immediate ReleaseChicago, IL – December 11, 2024 – Stocks in this week’s article are Stryve Foods SNAX, Nevro NVRO, Canoo GOEV, MSA Safety Inc. MSA and VTEX VTEX.Bet on 5 Top-Ranked Stocks with...

NVRO : 5.84 (unch)
SNAX : 0.4549 (unch)
GOEV : 0.3700 (-9.60%)
VTEX : 5.02 (+3.72%)
MSA : 145.17 (+1.97%)
Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock...

NVRO : 5.84 (unch)
SNAX : 0.4549 (unch)
GOEV : 0.3700 (-9.60%)
VTEX : 5.02 (+3.72%)
MSA : 145.17 (+1.97%)
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 5.84 (unch)
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 5.84 (unch)
Nevro: Q1 Earnings Snapshot

Nevro: Q1 Earnings Snapshot

NVRO : 5.84 (unch)
Why Nevro Stock Lagged the Market on Thursday

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

NVRO : 5.84 (unch)
Nevro: Q4 Earnings Snapshot

Nevro: Q4 Earnings Snapshot

NVRO : 5.84 (unch)

Business Summary

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation...

See More

Key Turning Points

3rd Resistance Point 5.87
2nd Resistance Point 5.87
1st Resistance Point 5.85
Last Price 5.84
1st Support Level 5.83
2nd Support Level 5.83
3rd Support Level 5.81

See More

52-Week High 13.84
Fibonacci 61.8% 9.76
Fibonacci 50% 8.50
Fibonacci 38.2% 7.24
Last Price 5.84
52-Week Low 3.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro